News & Articles

Results per page

25

2 Articles Found | Selected Filters:

Ascelia Pharma Clear Filters

Industry NewsClinical Diagnostics

Independent market research says 84% of US Healthcare professionals likely to use Orviglance in target population

Research confirms the unmet need for an effective alternative to unenhanced MRI and a safe alternative to GBCAs

22 Mar 2022

Industry NewsDrug discovery > Clinical Development

Ascelia Pharma presents study showing comparable efficacy of Orviglance lesion visualization and detection to Gadolinium

Novel contrast agent is being developed to address the medical need of patients with poor kidney function

23 Nov 2021